Data / Drug companies / Ephedrine sulfate
Ephedrine sulfate: 26 companies and 41 products in the FDA NDC directory
Ephedrine sulfate is listed in the FDA National Drug Code Directory by 26 companies, with 41 products in commercial distribution. 28 of the products (68.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection; injection, solution; tablet, film coated, and the newest product started marketing on July 8, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 26
- Products
- 41
- Generic (ANDA) products
- 28 (68.3%)
- Application numbers
- 20
- Routes
- Intravenous, Oral
- Brand names
- Emerphed PFS, Akovaz, Bronkaid Max, Emerphed
- openFDA record search
- api.fda.gov
Companies that list ephedrine sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Medical Purchasing Solutions, LLC | 6 | injection | Generic drugs (ANDA) | April 21, 2022 |
| Par Health USA, LLC | 4 | injection; injection, solution | New drug applications (NDA) | January 31, 2024 |
| Fresenius Kabi USA, LLC | 3 | injection | Generic drugs (ANDA) | July 7, 2025 |
| Nexus Pharmaceuticals LLC | 3 | injection | New drug applications (NDA) | March 1, 2023 |
| Exela Pharma Sciences, LLC | 2 | injection | New drug applications (NDA) | May 10, 2021 |
| Gland Pharma Limited | 2 | injection | Generic drugs (ANDA) | January 16, 2025 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection | Generic drugs (ANDA) | December 20, 2024 |
| Amneal Pharmaceuticals LLC | 1 | injection | Generic drugs (ANDA) | October 23, 2019 |
| Baxter Healthcare Corporation | 1 | injection | Generic drugs (ANDA) | July 8, 2026 |
| CVS Pharmacy | 1 | tablet, film coated | Over the counter monograph drugs | December 28, 2022 |
| Caplin Steriles Limited | 1 | injection | Generic drugs (ANDA) | August 15, 2024 |
| Civica, Inc. | 1 | injection | Generic drugs (ANDA) | March 29, 2021 |
| Dr. Reddy's Laboratories Inc. | 1 | injection | Generic drugs (ANDA) | October 4, 2021 |
| Eugia US LLC | 1 | injection | Generic drugs (ANDA) | June 14, 2021 |
| Foundation Consumer Healthcare | 1 | tablet, coated | Over the counter monograph drugs | September 1, 2020 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, solution | New drug applications (NDA) | October 21, 2018 |
| Lifestar Pharma LLC | 1 | injection | Generic drugs (ANDA) | April 15, 2022 |
| NorthStar Rx LLC | 1 | injection | Generic drugs (ANDA) | December 2, 2020 |
| NorthStar RxLLC | 1 | injection | Generic drugs (ANDA) | May 1, 2024 |
| ProPharma Distribution | 1 | injection | Generic drugs (ANDA) | April 15, 2022 |
| Remedyrepack Inc. | 1 | injection | Generic drugs (ANDA) | August 12, 2025 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | April 15, 2023 |
| Sandoz Inc | 1 | injection | Generic drugs (ANDA) | October 1, 2017 |
| Somerset Therapeutics, LLC | 1 | injection | Generic drugs (ANDA) | November 7, 2024 |
| Walgreen Company | 1 | tablet, film coated | Over the counter monograph drugs | July 22, 2022 |
| Xiromed, LLC | 1 | injection | Generic drugs (ANDA) | April 21, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 34 | 82.9% |
| Injection, solution | 4 | 9.8% |
| Tablet, film coated | 2 | 4.9% |
| Tablet, coated | 1 | 2.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 28 | 68.3% |
| New drug applications (NDA) | 10 | 24.4% |
| Over the counter monograph drugs | 3 | 7.3% |
Pharmacologic classes
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.